Bon Secours Health System Vice President Rhodes Ritenour testified against proposed Virginia state legislation to require more accountability from 340B hospitals about how they use 340B program revenues. State House Del. Kathy Tran, the bill's sponsor, is seated behind him.
A Virginia House subcommittee last week voted 3-2 against a Democrat’s bill to require more accountability from 340B hospitals about how they use 340B program revenues.
In a reversal of their parties’ normal stances on 340B nationally, Democrats
Mississippi legislators have reintroduced legislation to stop drug companies from denying 340B covered entities access to the manufacturers’ products if the entity uses contract pharmacies.
Mississippi legislators have reintroduced legislation to stop drug manufactures from denying 340B covered entities access to the manufacturers’ products if the entity uses contract pharmacies.
Mississippi joins Missouri in making a second attempt to pass legislation modeled
Expect the 340B program to be get signficant attention at the federal and state level this year, 340B Report Publisher and CEO Ted Slafsky says.
In his inaugural column for Verity Solutions, 340B Report Publisher and CEO Ted Slafsky offers insights “on what to expect in Washington, D.C., and the states in 2023 when it comes to the 340B program.”
Virginia Del. Kathy Tran (D) says her bill to to require more accountability from 340B hospitals was prompted by The New York Times' investigation of alleged 340B program misuse detrimental to a Richmond hospital in a predominantly Black neighborhood.
A Virginia House subcommittee is voting later today on a Democrat’s bill to require more accountability from 340B hospitals—a direct consequence of The New York Times’ exposé about alleged 340B program misuse involving a Richmond, Va., hospital.
Missouri lawmakers have reintroduced legislation to prohibit drug manufactures from denying 340B covered entities access to manufacturers’ products if the covered entity uses contract pharmacies.
Missouri lawmakers have reintroduced legislation to prohibit drug manufactures from denying 340B covered entities access to manufacturers’ products if the covered entity uses contract pharmacies. The language is modeled on the first-of-its kind law passed in Arkansas in
“It’s not hyperbole to say if this is put into place, we’re going to have to cut services and cut staffing," Mark Malahosky of Trillium Health says of New York State's plan to shift Medicaid managed care prescription drug benefits into Medicaid fee for service.
With a two-year implementation delay nearly over, New York State is poised to fold its Medicaid managed care prescription drug benefits into its Medicaid fee for service system on April 1. State 340B health care providers that serve
Pennsylvania rescinded a new Medicaid policy document that said contract pharmacies could not dispense 340B-purchased drugs to Medicaid beneficiaries.
The Pennsylvania Department of Human Services yesterday rescinded Medicaid policy guidance dated Dec. 22 and effective Jan. 1 that forbade 340B covered entities’ contract pharmacies from dispensing 340B-purchased drugs to Medicaid beneficiaries.
A bill in Oregon would prohibit discriminatory practices by PBMs and insurance plans against 340B pharmacies.
Oregon legislators have introduced a bill that would prohibit discriminatory practices by pharmacy benefit managers and insurance plans against 340B pharmacies, including reimbursing a 340B pharmacy less for prescription drugs compared with non-340B pharmacies.
Pennsylvania 340B covered entities are alarmed about the state's position that contract pharmacies may not dispense 340B drugs to any Medicaid beneficiaries.
Pennsylvania 340B health centers and hospitals are alarmed about a Dec. 22 state human services department notice to providers that 340B covered entities’ contract pharmacies “must dispense non-340B-purchased drugs to [Medicaid] beneficiaries in the [fee for service] and
The Michigan Senate defeated legislation that hospitals say would have weakened a new state law that protects 340B contract pharmacy arrangements.
The Michigan Senate has defeated legislation that hospitals say would have removed language from a nearly year-old state law that stops payers, pharmacy benefit managers, or other third parties from requiring 340B claims modifiers except as required to
